Table Of Content

JOURNAL OF THE NEUROLOGICAL SCIENCES ELSEVIER Journal of the Neurological Sciences 126 (1994) 247-249 Author Index (V ol. 126) Abe, K., see Aoki, M. (126) 77 Fukushima, T., Ikeda, T., Uyama, E., Uchino, M., Okabe, H. and Ami, Y., see Mizusawa, H. (126) 101 Ando, M. Ando, M., see Fukushima, T. (126) 30 Cognitive event-related potentials and brain magnetic resonance Aoki, M., Ogasawara, M., Matsubara, Y., Narisawa, K., Nakamura, imaging in HTLV-1 associated myelopathy (HAM) (126) 30 S., Itoyama, Y. and Abe, K. Gallo, P., Sivieri, S., Rinaldi, L., Yan, X.-B., Lolli, F., De Rossi, A. Familial amyotrophic lateral sclerosis (ALS) in Japan associated and Tavolato, B. with H46R mutation in Cu/Zn superoxide dismutase gene: a Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflam- possible new subtype of familial ALS (126) 77 matory diseases of the central nervous system (126) 49 Araki, E., Kobayashi, T., Kohtake, N., Goto, I. and Hashimoto, T. Gerritsen van der Hoop, R., Hamers, F.P.T., Neijt, J.P., Veldman, A riboflavin-responsive lipid storage myopathy due to multiple H., Gispen, W.H. and Jennekens, F.G.I. acyl-CoA dehydrogenase deficiency: an adult case (126) 202 Protection against cisplatin induced neurotoxicity by ORG 2766: Araki, K., see Kono, I. (126) 162 Artner-Dworzak, E., see Secnik, P. (126) 88 histological and electrophysiological evidence (126) 109 Gerstenbrand, F., see Secnik, P. (126) 88 Azulay, J.P., see Blin, O. (126) 225 Gispen, W.H., see Gerritsen van der Hoop, R. (126) 109 Baum, K., see Flechtner, K.-M. (126) 146 Godefroy, O., Lhullier, C. and Rousseaux, M. Berry, P.A., see Burchill, S.A. (126) 126 Reliability of reaction time measurements in brain-damaged pa- Blin, O., Rascol, O., Azulay, J.P., Serratrice, G. and Nieoullon, A. tients (126) 168 A single report of hemiplegic arm stretching related to yawning: Goto, I., see Araki, E. (126) 202 further investigation using apomorphine administration (126) 225 Goto, I., see Ohyagi, Y. (126) 237 Bousseau, A., see Sindou, P. (126) 133 Govan, G.G., Smith, P.R., Kellar-Wood, H., Schapira, A.H.V. and Burchill, S.A., Berry, P.A. and Lewis, I.J. Harding, A.E. Changing expression of GTPase activating proteins with differen- HLA class II genotypes in Leber’s hereditary optic neuropathy tiation in neuroblastoma (126) 126 (126) 193 Gredal, O., see Witt, M.R. (126) 206 Cangiotti, A., see Provinciali, L. (126) 54 Carboni, V., see Provinciali, L. (126) 54 Haltia, M., see Kiuru, S. (126) 40 Chiba, A., see Hitoshi, S. (126) 219 Hamers, F.P.T., see Gerritsen van der Hoop, R. (126) 109 Cifra, S., see Secnik, P. (126) 88 Haponik, E.F., see Ely, E.W. (126) 232 Cinti, S., see Provinciali, L. (126) 54 Harding, A.E. Neurogenetics update (126) 90 Couratier, P., see Sindou, P. (126) 133 Crockard, A.D., see Droogan, A.G. (126) 172 Harding, A.E., see Govan, G.G. (126) 193 Hashimoto, T., see Araki, E. (126) 202 Dekermendjian, K., see Witt, M.R. (126) 206 Hawkins, S.A., see Droogan, A.G. (126) 172 Delli Pizzi, C., see Di Muzio, A. (126) 153 Hayashi, H., see Kato, S. (126) 62 De Rossi, A., see Gallo, P. (126) 49 Hikawa, N., see Sango, K. (126) 1 Di Muzio, A., Delli Pizzi, C., Lugaresi, A., Ragno, M. and Uncini, A. Hitoshi, S., Kusunoki, S., Chiba, A., Takatsu, R., Sunada, Y., Nuk- Benign monomelic amyotrophy of lower limb: a rare entity with a ina, N., Tai, T. and Kanazawa, I. characteristic muscular CT (126) 153 Cerebellar ataxia and polyneuropathy in a patient with IgM Droogan, A.G., Crockard, A.D., Hawkins, S.A. and McNeill, T.A. M-protein specific to the Gal(81-3)GalNAc epitope (126) 219 v6 T cell distribution in cerebrospinal fluid and peripheral blood Ho, J., see Kay, R. (126) 84 of patients with multiple sclerosis (126) 172 H6ég, A., see Ma, K.-C. (126) 184 Dyck, P.J., see Thyagarajan, D. (126) 149 Hopper, C., see Sciote, J.J. (126) 15 Hori, M., see Mizusawa, H. (126) 101 Ely, E.W., McCall, W.V. and Haponik, E.F. Horie, H., see Sango, K. (126) 1 Multifactorial obstructive sleep apnea in a patient with Chiari Hugon, J., see Sindou, P. (126) 133 malformation (126) 232 Hunt, N.P., see Sciote, J.J. (126) 15 Esclaire, F., see Sindou, P. (126) 133 Ikeda, K., see Iwasaki, Y. (126) 228 Flechtner, K.-M. and Baum, K. Ikeda, T., see Fukushima, T. (126) 30 Mixed connective tissue disease: recurrent episodes of optic neu- Imamura, T., Tsuburaya, K. and Yamadori, A. ropathy and transverse myelopathy. Successful treatment with Peak time difference of time-density curve in contrast media plasmapheresis (126) 146 transit as an indicator of asymmetric cerebral perfusion (126) 197 248 Author Index / Journal of the Neurological Sciences 126 (1994) 247-249 Inoue, S., see Sango, K. (126) 1 Nakajima, K., see Kono, I. (126) 162 Itoh, Y., see Yamada, M. (126) 178 Nakamura, S., see Aoki, M. (126) 77 Itoyama, Y., see Aoki, M. (126) 77 Narisawa, K., see Aoki, M. (126) 77 Iwasaki, Y., Ikeda, K., Tagaya, N. and Kinoshita, M. Neijt, J.P., see Gerritsen van der Hoop, R. (126) 109 Magnetic resonance imaging and neuropathological findings in Nickander, K.K., Schmelzer, J.D., Rohwer, D.A. and Low, P.A. two patients with Creutzfeldt-Jakob disease (126) 228 Effect of a-tocopherol deficiency on indices of oxidative stress in Iwasaki, Y., see Mizusawa, H. (126) 101 normal and diabetic peripheral nerve (126) 6 Nie, X.J., see Ma, K.-C. (126) 184 Nielsen, M., see Witt, M.R. (126) 206 Jennekens, F.G.I., see Gerritsen van der Hoop, R. (126) 109 Nieoullon, A., see Blin, O. (126) 225 Nonaka, I., see Yamanouchi, Y. (126) 70 Kagawa, K., see Kono, I. (126) 162 Nukina, N., see Hitoshi, S. (126) 219 Kamata, T., see Yamada, M. (126) 178 Kameyama, T., see Mizusawa, H. (126) 101 Oda, M., see Kato, S. (126) 62 Kanazawa, I., see Hitoshi, S. (126) 219 Ogasawara, M., see Aoki, M. (126) 77 Kashima, K., see Kono, I. (126) 162 Ohman, S. Kato, S., Oda, M., Hayashi, H., Kawata, A. and Shimizu, T. Points of view concerning the diffusion theory for blood—CSF Participation of the limbic system and its associated areas in the barrier function and dysfunction (126) 240 dementia of amyotrophic lateral sclerosis (126) 62 Ohyagi, Y. and Goto, I. Kawata, A., see Kato, S. (126) 62 Does iron-catalyzed oxidation of neuronal hemoglobin contribute Kay, R., Lam, S., Wong, K.S., Wang, A. and Ho, J. to motor neuron degeneration? (126) 237 Response to thymectomy in Chinese patients with myasthenia Okabe, H., see Fukushima, T. (126) 30 gravis (126) 84 Olsson, Y., see Ma, K.-C. (126) 184 Kellar-Wood, H., see Govan, G.G. (126) 193 Ozawa, E., see Yamanouchi, Y. (126) 70 Kinoshita, M., see Iwasaki, Y. (126) 228 Kiuru, S., Matikainen, E., Kupari, M., Haltia, M. and Palo, J. Palo, J., see Kiuru, S. (126) 40 Autonomic nervous system and cardiac involvement in familial Parrak, V., see Secnik, P. (126) 88 amyloidosis, Finnish type (FAF) (126) 40 Passaquin, A.-C., see Metzinger, L. (126) 138 Kobayashi, M., see Mizusawa, H. (126) 101 Poindron, P., see Metzinger, L. (126) 138 Kobayashi, T., see Araki, E. (126) 202 Pollard, J.D., see Watson, S.L. (126) 116 Kohtake, N., see Araki, E. (126) 202 Provinciali, L., Cangiotti, A., Tulli, D., Carboni, V. and Cinti, S. Kono, I., Ueda, Y., Nakajima, K., Araki, K., Kagawa, K. and Kashima, Skin abnormalities and autonomic involvement in the early stage K. of amyotrophic lateral sclerosis (126) 54 Subcortical impairment in subclinical hepatic encephalopathy Puschendorf, B., see Secnik, P. (126) 88 (126) 162 Kupari, M., see Kiuru, S. (126) 40 Ragno, M., see Di Muzio, A. (126) 153 Kushida, S., see Mizusawa, H. (126) 101 Rascol, O., see Blin, O. (126) 225 Kusunoki, S., see Hitoshi, S. (126) 219 Reiber, H. The hyperbolic function: a mathematical solution of the protein Lam, S., see Kay, R. (126) 84 flux /CSF flow model for blood—CSF barrier function. A reply to Lechner, H., see Walzl, B. (126) 25 the letter by S. Ohman (J. Neurol. Sci., 126 (1994) 240-242) (126) Lewis, I.J., see Burchill, S.A. (126) 126 243 Lhullier, C., see Godefroy, O. (126) 168 Rinaldi, L., see Gallo, P. (126) 49 Lolli, F., see Gallo, P. (126) 49 Rodier, G., Tranchant, C., Mohr, M. and Warter, J.M. Low, P.A., see Nickander, K.K. (126) 6 Neurobehavioral changes following bilateral infarct in the cau- Lugaresi, A., see Di Muzio, A. (126) 153 date nuclei: a case report with pathological analysis (126) 213 Rohwer, D.A., see Nickander, K.K. (126) 6 Ma, K.-C., Nie, X.J., H66g, A., Olsson, Y. and Zhang, W.W. Rousseaux, M., see Godefroy, O. (126) 168 Reactive astrocytes in viral infections of the human brain express Rowlerson, A.M., see Sciote, J.J. (126) 15 endothelin-like immunoreactivity (126) 184 Matikainen, E., see Kiuru, S. (126) 40 Sango, K., Verdes, J.M., Hikawa, N., Horie, H., Tanaka, S.-i., Inoue, Matsubara, Y., see Aoki, M. (126) 77 S., Sotelo, J.R. and Takenaka, T. Matsumura, M., see Mizusawa, H. (126) 101 Nerve growth factor (NGF) restores depletions of calcitonin McCall, W.V., see Ely, E.W. (126) 232 gene-related peptide and substance P in sensory neurons from McNeill, T.A., see Droogan, A.G. (126) 172 diabetic mice in vitro (126) 1 Metzinger, L., Passaquin, A.-C., Vernier, A., Thiriet, N., Warter, Schapira, A.H.V., see Govan, G.G. (126) 193 J.-M. and Poindron, P. Schmelzer, J.D., see Nickander, K.K. (126) 6 Lazaroids enhance skeletal myogenesis in primary cultures of Sciote, J.J., Rowlerson, A.M., Hopper, C. and Hunt, N.P. dystrophin-deficient mdx mice (126) 138 Fibre type classification and myosin isoforms in the human mas- Miwa, M., see Mizusawa, H. (126) 101 seter muscle (126) 15 Miyatake, T., see Yamada, M. (126) 178 Secnik, P., Artner-Dworzak, E., Cifra, S., Parrak, V., Puschendorf, B. Mizusawa, H., Kushida, S., Matsumura, M., Tanaka, H., Ami, Y., and Gerstenbrand, F. Hori, M., Kobayashi, M., Uchida, K., Yagami, K., Yoshizawa, T.., Release of muscle proteins in brain stroke patients (126) 88 Kameyama, T., Iwasaki, Y. and Miwa, M. Serratrice, G., see Blin, O. (126) 225 A neuropathological study of paraparetic rats injected with Shimizu, T., see Kato, S. (126) 62 HTLV-I-producing T cells (126) 101 Sindou, P., Couratier, P., Esclaire, F., Yardin, C., Bousseau, A. and Mohr, M., see Rodier, G. (126) 213 Hugon, J. Author Index / Journal of the Neurological Sciences 126 (1994) 247-249 Prevention of HIV coat protein (gp120) toxicity in cortical cell Walzl, B., Walzl, M. and Lechner, H. cultures by riluzole (126) 133 Extracorporeal fibrinogen and platelet precipitation as a new Sivieri, S., see Gallo, P. (126) 49 haemorheological treatment for acute stroke (126) 25 Smith, P.R., see Govan, G.G. (126) 193 Walzl, M., see Walzl, B. (126) 25 Sotelo, J.R., see Sango, K. (126) 1 Wang, A., see Kay, R. (126) 84 Sunada, Y., see Hitoshi, S. (126) 219 Warter, J.-M., see Metzinger, L. (126) 138 Warter, J.M., see Rodier, G. (126) 213 Tagaya, N., see Iwasaki, Y. (126) 228 Watson, S.L., Westland, K. and Pollard, J.D. Tai, T., see Hitoshi, S. (126) 219 An electrophysiological and histological study of trypsin induced Takatsu, R., see Hitoshi, S. (126) 219 demyelination (126) 116 Takenaka, T., see Sango, K. (126) 1 Westland, K., see Watson, S.L. (126) 116 Tanaka, H., see Mizusawa, H. (126) 101 Witt, M.R., Gredal, O., Dekermendjian, K., Undén, M. and Nielsen, Tanaka, S.-i., see Sango, K. (126) 1 M. Tavolato, B., see Gallo, P. (126) 49 Calcium homeostasis in fibroblasts from patients with amy- Thiriet, N., see Metzinger, L. (126) 138 otrophic lateral sclerosis (126) 206 Thyagarajan, D. and Dyck, P.J. Wong, K.S., see Kay, R. (126) 84 Influence of local tissue temperature on vibration detection threshold (126) 149 Yagami, K., see Mizusawa, H. (126) 101 Tranchant, C., see Rodier, G. (126) 213 Yamada, M., Yuki, N., Kamata, T., Itoh, Y. and Miyatake, T. Tsuburaya, K., see Imamura, T. (126) 197 Expression of a blood group B antigen-related glycoepitope in Tulli, D., see Provinciali, L. (126) 54 human dorsal root ganglion cells (126) 178 Yamadori, A., see Imamura, T. (126) 197 Uchida, K., see Mizusawa, H. (126) 101 Yamanouchi, Y., Ozawa, E. and Nonaka, I. Uchino, M., see Fukushima, T. (126) 30 Autosomal recessive distal muscular dystrophy: normal expres- Ueda, Y., see Kono, I. (126) 162 sion of dystrophin, utrophin and dystrophin-associated proteins Uncini, A., see Di Muzio, A. (126) 153 in muscle fibers (126) 70 Undén, M., see Witt, M.R. (126) 206 Yan, X.-B., see Gallo, P. (126) 49 Uyama, E., see Fukushima, T. (126) 30 Yardin, C., see Sindou, P. (126) 133 Yoshizawa, T., see Mizusawa, H. (126) 101 Veldman, H., see Gerritsen van der Hoop, R. (126) 109 Yuki, N., see Yamada, M. (126) 178 Verdes, J.M., see Sango, K. (126) 1 Vernier, A., see Metzinger, L. (126) 138 Zhang, W.W., see Ma, K.-C. (126) 184 JOURNAL OF THE NEUROLOGICAL SCIENCES Journal of the Neurological Sciences 126 (1994) 250-251 Subject Index (Vol. 126) Aging, (126) 101 Dynamic CT, (126) 197 Amygdala, (126) 62 Dystrophin, (126) 70 Amyloid cardiopathy, (126) 40 Dystrophin-associated glycoproteins (DAGs), (126) 70 Amyloid polyneuropathy, (126) 40 Dystrophin-associated proteins (DAPs), (126) 70 Amyotrophic lateral sclerosis, (126) 54, (126) 62, (126) 206 Dystrophin deficiency, (126) 138 Antibody, (126) 178 Antioxidant, (126) 138 Electrophysiology, (126) 109 Apomorphine, (126) 225 Emotion, (126) 62 ATPase, (126) 15 Endothelin, (126) 184 Autonomic nervous system, (126) 54 Event-related potentials (ERPs), (126) 30 Autonomic neuropathy, (126) 40 Autosomal recessive distal muscular dystrophy, (126) 70 Familial ALS, (126) 77 Familial amyloidosis, Finnish type, (126) 40 Basal ganglia, (126) 213, (126) 225, (126) 228 Fibrinogen, (126) 25 Bedsores, (126) 54 Fibroblast, (126) 206 Behavioral functions, (126) 213 Biophysics of diffusion, (126) 243 Gangliosides, (126) 219 Blood group antigen, (126) 178 Gelsolin, (126) 40 Blood viscosity, (126) 25 Glucocorticoids, (126) 138 Bradykinin, (126) 206 Glutamate, (126) 133 Brain atrophy, (126) 30 Glutaric acidemia type II, (126) 202 Brain stroke, (126) 88 Glutathione, (126) 6 Glycolipid, (126) 178, (126) 219 Calcitonin gene-related peptide, (126) 1 Glycoprotein, (126) 178 Calcium, (126) 206 Granular cell, (126) 219 Cardiovascular reflexes, (126) 40 Growth, (126) 126 Caudate nucleus, (126) 213 GTPase activating proteins, (126) 126 CD45 isoforms, (126) 172 Cerebellar ataxia, (126) 219 Haemorheology, (126) 25 Cerebral circulation, (126) 197 Hemipandiculation, (126) 225 Cerebral evoked potentials, (126) 30 Hemoglobin, (126) 237 Cerebrospinal fluid, (126) 49, (126) 172, (126) 243 Hepatic encephalopathy, (126) 162 Chiari malformation, (126) 232 Hereditary amyloidosis, (126) 40 Chinese, (126) 84 Herpes simplex encephalitis, (126) 184 Cisplatin, (126) 109 Histology, (126) 109 Collagen fibrils, (126) 54 HIV, (126) 49 Conduction block, (126) 116 HIV coat protein gp120, (126) 133 Conjugated diene, (126) 6 HLA, (126) 193 Creutzfeldt-Jakob disease, (126) 228 HTLV-1 associated myelopathy (HAM), (126) 30, (126) 101 CSF flow rate, (126) 243 Human, (126) 15 CSF/serum concentration quotients, (126) 243 Hydroperoxide, (126) 6 Cu/Zn superoxide dismutase gene, (126) 77 Hypointensity, (126) 228 Dementia, (126) 62 IgM paraproteinemia, (126) 219 Demyelination, (126) 116 Immunohistochemistry, (126) 178, (126) 184 Dentate nucleus, (126) 219 Inferior olive, (126) 219 Diabetic neuropathy, (126) 1, (126) 6 Inflammation, (126) 184 Differentiation, (126) 126 Interleukin-10, (126) 49 Digital subtraction angiography, (126) 197 Intraneural injection, (126) 116 Dorsal root ganglion, (126) 1, (126) 178 Iron, (126) 237 Duchenne muscular dystrophy, (126) 70, (126) 138 Ischaemic stroke, (126) 25 Subject Index / Journal of the Neurologcial Sciences 126 (1994) 250-251 Late-onset, (126) 202 Oxidative stress, (126) 6 Lazaroids, (126) 138 Oxygen free radical, (126) 6 Leber’s hereditary optic neuropathy, (126) 193 Limbic system, (126) 62 Peripheral neuropathy, (126) 101 Lipid storage myopathy, (126) 202 Plasmapheresis, (126) 25, (126) 146 Loss of psychic self activation, (126) 213 PML, (126) 184 Polyneuropathy, (126) 219 Macrophage, (126) 116 Prevention, (126) 109 Magnetic resonance imaging (MRI), (126) 30, (126) 146 Proteinase, (126) 116 Masseter, (126) 15 Protein diffusion, (126) 243 max, (126) 138 Melanocortin, (126) 109 Radiculopathy, (126) 101 Methodology, (126) 168 Rat, (126) 101 Mitochondrial DNA, (126) 193 Reaction time measurement, (126) 168 Mixed connective tissue disease, (126) 146 Retinoic acid, (126) 126 Monomelic amyotrophy, (126) 153 Riboflavin treatment, (126) 202 Motor neuron degeneration, (126) 237 Riluzole, (126) 133 Mouse, (126) 1 RT-PCR, (126) 126 Mouse skeletal muscle cultures, (126) 138 MRI, (126) 228 Sensory neuropathy, (126) 178 Multiple acyl-CoA dehydrogenase deficiency, (126) 202 Sharp syndrome, (126) 146 Multiple sclerosis, (126) 172, (126) 193 Single photon emission CT, (126) 197 Muscle computerized tomography, (126) 153 Somatosensory evoked potential, (126) 162 Muscular proteins, (126) 88 Spinal muscular atrophy, (126) 153 Mutation, (126) 77 SSPE, (126) 184 Myasthenia gravis, (126) 84 Substance P, (126) 1 Myosin, (126) 15, (126) 88 Subtype, (126) 77 Sympathetic, (126) 6 Nerve conduction, (126) 6 Syringobulbia-myelia, (126) 232 Nerve growth factor (NGF), (126) 1 v6 T cells, (126) 172 Neuroblastoma, (126) 126 Neurological diseases, (126) 49 Temperature influence on sensory threshold, (126) 149 Neuronal cultures, (126) 133 Thrombolytic therapy, (126) 197 Neurophysiology, (126) 168 Thymectomy, (126) 84 Neuropsychology, (126) 168 Tropical spastic paraparesis (TSP), (126) 101 Neurotensin, (126) 206 Trypsin, (126) 116 Neurotoxicity, (126) 109, (126) 133 Utrophin, (126) 70 Obstructive sleep apnea, (126) 232 B-Oxidation, (126) 202 Vibratory detection threshold, (126) 149